Biohaven shares rose about 39% before trading, but the article gives no company news explaining the move. It does not change the company's outlook.
A share-price change alone does not show that Biohaven's treatments, sales, or business outlook changed. The article gives no company news to explain the move, so this report does not change the outlook for the business.
iSpecimen shares fell about 10%, but the article gives no company news explaining the move. It does not change the company's outlook.
Vogenx shares rose about 22%, but the article gives no company news explaining the move. It does not change the company's outlook.
Tyra Biosciences shares rose about 21%, but the article gives no company news explaining the move. It does not change the company's outlook.
Profusa shares rose about 15%, but the article gives no company news explaining the move. It does not change the company's outlook.
BeyondSpring shares rose about 13%, but the article gives no company news explaining the move. It does not change the company's outlook.
Follow Biohaven (BHVN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BHVN